drugset / Trial / NCT02023255
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to evaluate the safety and tolerability of multiple dose administration of JNJ-39393406 in young healthy participants, and subsequently in healthy elderly participants.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-39393406 | Small molecule | 50 mg | — |
| Subject | JNJ-39393406 | Small molecule | 150 mg | — |
| Subject | JNJ-39393406 | Small molecule | 450 mg | — |
| Subject | JNJ-39393406 | Small molecule | 1350 mg | — |
| Subject | JNJ-39393406 | Small molecule | 2700 mg | — |
Indications
No indication recorded.